Jianxia Guo

Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice

Jianxia Guo, Robert A. Parise, Erin Joseph et al. · Cancer Chemotherapy and Pharmacology · 2008 · 118 citations · Full text

Molecular Pharmacology, Tisssue Distribution, Allergy +10

Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study

Oliver Zivanovic, S. Dennis, Qin Zhou et al. · Journal of Clinical Oncology · 2021 · 117 citations · Full text

In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization

Dana M. Clausen, Jianxia Guo, Robert A. Parise et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 111 citations · Full text

Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers

Ramesh K. Ramanathan, Merrill J. Egorin, Julie L. Eiseman et al. · Clinical Cancer Research · 2007 · 87 citations · Full text

Crystal Structure of Human Glutathione <i>S</i>-Transferase A3-3 and Mechanistic Implications for Its High Steroid Isomerase Activity^,

Yijun Gu, Jianxia Guo, Ajay Pal et al. · Biochemistry · 2004 · 32 citations